Paper368243
Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice.
Radl J and 3 others. J Immunol, 1979. Cited by 147 papers, by iCite.
Cite this record
ConductScience Library. Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. Papers, record 368243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/368243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aging | Major topic |
| Paraproteinemias | Major topic |
| Paraproteins | Major topic |
| Animals | |
| Bone Marrow | |
| Clone Cells | |
| Fluorescent Antibody Technique | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Spleen | |
| Transplantation, Homologous |
Source PubMed
Cited by77
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 147 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41791669 | Engineering bone marrow in a dish-a bloody business: preclinical opportunities, translational use cases, and a call for consensus. | J Thromb Haemost | 2026 | https://conductscience.org/library/papers/41791669 | PubMed |
| 41627211 | Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models. | Blood Cancer Discov | 2026 | https://conductscience.org/library/papers/41627211 | PubMed |
| 41188965 | Human preclinical multiple myeloma in vitro models for disease modeling and therapy screening. | J Biol Eng | 2025 | https://conductscience.org/library/papers/41188965 | PubMed |
| 39695697 | Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma. | J Hematol Oncol | 2024 | https://conductscience.org/library/papers/39695697 | PubMed |
| 39353958 | DNA vaccines against GPRC5D synergize with PD-1 blockade to treat multiple myeloma. | NPJ Vaccines | 2024 | https://conductscience.org/library/papers/39353958 | PubMed |
| 38562904 | Endogenous CD28 drives CAR T cell responses in multiple myeloma. | bioRxiv | 2024 | https://conductscience.org/library/papers/38562904 | PubMed |
| 37629558 | Current and Future PET Imaging for Multiple Myeloma. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37629558 | PubMed |
| 37173940 | The Synthetic Collagen-Binding Peptide NIPEP-OSS Delays Mouse Myeloma Progression. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37173940 | PubMed |
| 37031341 | Molecular characterization stratifies VQ myeloma cells into two clusters with distinct risk signatures and drug responses. | Oncogene | 2023 | https://conductscience.org/library/papers/37031341 | PubMed |
| 34503090 | An Improved Animal Model of Multiple Myeloma Bone Disease. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503090 | PubMed |
| 34163520 | Animal Models of Multiple Myeloma Bone Disease. | Front Genet | 2021 | https://conductscience.org/library/papers/34163520 | PubMed |
| 34149703 | Laboratory Mice - A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma. | Front Immunol | 2021 | https://conductscience.org/library/papers/34149703 | PubMed |
| 33579905 | A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33579905 | PubMed |
| 33374627 | Current Understanding of Myelomatous Mesenchymal Stromal Cells Extended through Advances in Experimental Methods. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33374627 | PubMed |
| 32923989 | Characterization of the role of Samsn1 loss in multiple myeloma development. | FASEB Bioadv | 2020 | https://conductscience.org/library/papers/32923989 | PubMed |
| 32083236 | Differential Pain-Related Behaviors and Bone Disease in Immunocompetent Mouse Models of Myeloma. | JBMR Plus | 2020 | https://conductscience.org/library/papers/32083236 | PubMed |
| 31995627 | GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice. | PLoS One | 2020 | https://conductscience.org/library/papers/31995627 | PubMed |
| 31886918 | Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-Alpha. | J Bone Miner Res | 2020 | https://conductscience.org/library/papers/31886918 | PubMed |
| 31475039 | The Use of Murine Models for Studying Mechanistic Insights of Genomic Instability in Multiple Myeloma. | Front Genet | 2019 | https://conductscience.org/library/papers/31475039 | PubMed |
| 30874356 | Plasma cells: You are what you eat. | Immunol Rev | 2019 | https://conductscience.org/library/papers/30874356 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/368243
GET https://conductscience.org/api/papers/v1/368243/cited_by?page=2